Forecast: Healthcare Expenditure on Prescribed Medicines in the UK

The healthcare expenditure on prescribed medicines in the UK is forecasted to decrease slightly from €16.17 billion in 2024 to €16.10 billion by 2028. In 2023, this expenditure stood at approximately €16.20 billion. The yearly decrease in expenditure is marginal, less than 0.5% year-on-year, with a five-year CAGR projecting a minor decline. This indicates a stabilization or slight contraction in spending, possibly due to cost-control measures or efficiency gains in the healthcare sector.

Future trends to watch include:

• Potential impacts from policy changes aiming at cost reduction in pharmaceutical pricing.
• Innovations in generic medicines and biosimilars leading to reduced spending.
• External economic conditions such as inflation affecting the healthcare budget allocation.
• Technological advancements in personalized medicine potentially altering prescription patterns and expenditures.